S2k-Leitlinie zur Therapie der Psoriasis bei Kindern und Jugendlichen – Kurzfassung Teil 1 (2019) Eisert L, Augustin M, Bach S, Dittmann M, Eiler R, Fölster-Holst R, Gerdes S, et al. Journal article Information-seeking and use of information resources among melanoma patients of German skin cancer centers Informationssuche und Nutzung von Informationsquellen durch Melanompatienten deutscher Hautkrebszentren (2018) Brütting J, Bergmann M, Garzarolli M, Rauschenberg R, Weber C, Berking C, Tilgen W, et al. Journal article Importance of the RNA Binding Protein Hu-antigen R in malignant Melanoma (2018) Liebig J, Boßerhoff AK Conference contribution Extracellular Acidosis leads to the Development of a senescent-like Phenotype and molecular Reprogramming of human Melanoma Cells (2018) Böhme I, Boßerhoff AK Conference contribution CYLD - A potential Mediator of tissue-specific Melanoma Metastasis (2018) Schott M, de Jel MM, Boßerhoff AK, Kuphal S Conference contribution SiRNA-Knockdown einer neuen Argonaute2 Spleißvariante verringert die tumorigenen Eigenschaften von Melanomzellen. (2018) Linck L, Boßerhoff AK Conference contribution, Abstract of a poster Positionspapier: Telemedizin in der Berufsdermatologie - Aktueller Stand und Perspektiven (2018) Elsner P, Bauer A, Diepgen TL, Drexler H, Fartasch M, John SM, Schliemann S, et al. Journal article Characterization of Checkpoint Inhibitor-associated Diabetes mellitus - Experience in 12 Patients (2018) Satzger I, Momma M, Thoms KM, Eigentler T, Schultz E, Loquai C, Zimmer L, et al. Conference contribution Anti-PD-1 Therapy in SUFU mutant Patients with Gorlin-Goltz Syndrome (2018) Moreira A, Kirchberger MC, Toussaint F, Erdmann M, Schuler G, Heinzerling L Conference contribution Dry Mouth under Immune Checkpoint Inhibitors: an Analysis of 29 Patients from 10 German Skin Cancer Centers (2018) Hensen J, Thoms KM, Kaehler K, Gutzmer R, Zimmer L, Zacher M, Alter M, et al. Conference contribution